NAICS 424210: Drugs and Druggists
This industry comprises establishments primarily engaged in the merchant wholesale distribution of biological and medical products; botanical drugs and herbs; and pharmaceutical products intended for internal and/or external consumption in such forms as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

Illustrative Examples:

Antibiotics merchant wholesalers
Endocrine substances merchant wholesalers
Blood derivatives merchant wholesalers
In-vitro and in-vivo diagnostics merchant wholesalers
Drugs merchant wholesalers
Botanicals merchant wholesalers
Vaccines merchant wholesalers
Cosmetics merchant wholesalers
Vitamins merchant wholesalers
Veterinarians' medicines merchant wholesalers

ExioML sector: Wholesale trade and commission trade services, except of motor vehicles and motorcycles (51)
Region: US | Year: 2022
Sector value added: 810352.883944 M EUR | Employment: 3730.44587599 thousand persons
Sector GHG emissions: 6107301971.21 kg CO2 eq | Energy carrier net total: 113230.446126 TJ | Carbon intensity: 0.007536595589671585

Company: Astrazeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP manufactures, fabricates, and processes drugs in pharmaceutical preparations. The Company focuses on several therapeutic areas such as cardiovascular and metabolic, gastrointestinal, neuroscience, oncology, respiratory, and infection. AstraZeneca Pharmaceuticals operates globally.